Clinical trials
Ventricular Tachycardia clinical trials
Below are recruiting ventricular tachycardia clinical trials, each written for real people, not researchers. We’re tracking 75 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07148089RecruitingPhase 1
Gene therapy study for CPVT heart condition
This trial tests a new gene therapy called SGT-501 for people with a genetic heart condition called CPVT, which can cause dangerous fast heartbeats. The goal is to see if the treatment can reduce these episodes.
Boston, MassachusettsAges 7 years+ - NCT07263139RecruitingPhase 2
Testing AGP100 for CPVT heart condition
This trial tests a new drug called AGP100 for people with CPVT, a genetic heart condition that causes dangerous heartbeats during exercise. The goal is to see if AGP100 can safely reduce these abnormal heart rhythms.
OsloAges 18–75 - NCT05258422Enrolling by invitationPhase 2
Radiation ablation for recurring heart rhythm tachycardia
This study tests a targeted form of radiation therapy to stop a dangerous, repeat heart rhythm called ventricular tachycardia. It’s for people whose rhythm keeps coming back even after standard treatments like antiarrhythmic medications and prior heart procedure studies.
Montreal, QuebecAges 18 years+ - NCT03360227Recruiting
Registry after heart device implantation planning
This is a registry study that records information from people before they get a heart-related device implanted. It may help doctors understand how the team’s tests and planning relate to the procedure and outcomes later on.
DüsseldorfAges 18–80 - NCT05765175Recruiting
Radioablation versus repeat ablation for hard-to-treat VT
This trial compares a heart procedure using targeted radiation (called radioablation) to a repeat catheter ablation for people with high-risk, hard-to-control ventricular tachycardia (VT). It aims to find which approach is safer and works better after standard ablation and amiodarone have not stopped the abnormal rhythm.
Los Angeles, CaliforniaAges 18 years+ - NCT07201506Recruiting
Ultrasound-guided ablation for heart rhythm problems
This study uses a special ultrasound camera on a thin tube inside your heart (intracardiac echocardiography) to help doctors see the area causing your heart rhythm problem more clearly during the standard procedure (ablation). It may help them burn the wrong tissue more precisely.
BaselAges 18 years+ - NCT05047198RecruitingPhase 3
Catheter procedures to stop dangerous heart rhythm episodes
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
Ottawa, OntarioAges 55 years+ - NCT06661278Recruiting
Exercise testing in kids with inherited heart rhythm conditions
This study looks at how children with certain genetic heart rhythm problems, like long QT syndrome, respond to exercise. It may help doctors understand how to better manage these conditions.
LondonAges 6–16 - NCT06669299Recruiting
A heart-rhythm test after ablation to guide next steps
This trial uses a non-invasive stimulation test (NIPS) about a week after a successful ablation procedure for ventricular tachycardia (VT). It aims to see if the test can help doctors decide on further treatment to prevent the fast heart rhythm from returning.
Milan, ItalyAges 18 years+ - NCT06703489Recruiting
New catheter for ventricular tachycardia
This trial tests a new catheter system (Sphere-9 and Affera) to treat a fast, dangerous heartbeat called ventricular tachycardia (VT) in people with heart scarring. It aims to see if this system is safe and effective at stopping VT, especially if past treatments haven't worked.
Boston, MassachusettsAges 18–85 - NCT06743789Recruiting
Radiation therapy for ventricular tachycardia: one or three sessions
This trial tests whether a single session of targeted radiation (radioablation) is as effective as three sessions for treating a dangerous heart rhythm called ventricular tachycardia in people with heart muscle disease. It's for those who continue to have episodes despite medication and catheter ablation.
New York, New YorkAges 18–90 - NCT06607471Recruiting
Study on non-ischemic heart muscle diseases
This study looks at different types of heart muscle diseases that are not caused by blocked arteries (non-ischemic cardiomyopathies). It aims to better understand how to diagnose, predict outcomes, and treat these conditions by gathering information from many patients over time.
Milan, MilanoAges 18 years+ - NCT05594368RecruitingPhase 1
Test targeted radiation to treat recurrent ventricular tachycardia
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
OstravaAges 18 years+ - NCT07324031Recruiting
Study of a new under-the-skin defibrillator (the Parasternal EV-ICD)
This study tests a new type of defibrillator that goes underneath the skin, near your breastbone, to protect against dangerous heart rhythms. It may be an option if you need an ICD but haven't had certain prior chest surgeries or devices.
Scottsdale, ArizonaAges 18 years+ - NCT07503769Enrolling by invitation
Dual-energy cardiac ablation for ventricular arrhythmia
This study tests a new method using two types of energy to treat a fast heartbeat coming from the lower heart chambers. It is designed for people whose symptoms have not been controlled by medication and who do not have other serious heart conditions.
Ningbo, ZhejiangAges 18–75 - NCT06294028Recruiting
Ablation vs Defibrillator for Well-Tolerated Fast Heartbeat
This study compares two treatments for a fast heartbeat called ventricular tachycardia in people with prior heart attacks and relatively preserved heart function: one uses heat energy (ablation) to fix the electrical problem, and the other places an implantable defibrillator that shocks the heart to restore normal rhythm. The goal is to find which approach works better for people whose symptoms are well-tolerated.
Toulouse, FranceAges 18–90 - NCT05888662Recruiting
Compare two catheter approaches to treat ventricular tachycardia
This study compares an “outer heart” catheter approach (epicardial) versus an “inner heart” approach (endocardial-only) to treat a dangerous heart rhythm called ventricular tachycardia. It aims to see which approach works better and is safest for people with ischemic heart disease who are having their first ablation.
BordeauxAges 18 years+ - NCT05964660Recruiting
Ultrasound-guided imaging for heart rhythm ablation planning
This trial tests a way to use heart ultrasound images together with other heart scans to better plan catheter ablation for dangerous heart rhythm problems. It may help doctors identify the right target areas in the heart before you have the procedure.
Lübeck, Schleswig-HolsteinAges 18–100 - NCT07196176Recruiting
Heart rhythm test registry at University Hospital Düsseldorf
This registry collects information from people who have had or are scheduled to have a heart rhythm test or a procedure to restore a normal heartbeat at University Hospital Düsseldorf. It helps doctors understand more about heart rhythm problems and treatments over time.
DüsseldorfAges 18 years+ - NCT06745778Recruiting
Study of heart device signals in patients with left bundle pacing
This study looks at the electrical signals recorded by a special type of pacing lead placed in the heart's left bundle branch. It aims to understand how these signals change over time in people who already have an ICD or CRT-D device.
Wenzhou, ZhejiangAges 18 years+ - NCT04576130Recruiting
ICD study after cardiac arrest from an abnormal heart rhythm
This study looks at an implantable defibrillator (ICD) strategy in people who survived a cardiac arrest caused by an abnormal rhythm (ventricular fibrillation or ventricular tachycardia). It aims to reduce the risk of another dangerous rhythm after the blocked heart arteries are fully treated.
CopenhagenAges 18 years+ - NCT05720936Recruiting
Nerve block treatment for dangerous heart rhythm episodes
This trial looks at a procedure called a stellate ganglion block to calm dangerous, repeated heart rhythm attacks that haven’t improved with standard medicines. It may help reduce how often and how long these episodes last while you’re in the hospital.
Alessandria, ALAges Any age - NCT06940752Enrolling by invitation
A new way to treat stubborn heart rhythm problems
This study tests a special navigation technique to improve the success of repeat catheter ablation for ventricular arrhythmias, helping patients who haven't been helped by prior procedures or medications.
Atlanta, GeorgiaAges 21–100 - NCT03826524RecruitingPhase 4
Finding the best epinephrine dose after EMS-treated cardiac arrest
This study compares two epinephrine doses during the emergency treatment of out-of-hospital cardiac arrest. It aims to find a dose that works better and more safely for people who are in a shockable heart rhythm when paramedics arrive.
Victoria, British ColumbiaAges 18 years+
Hear when a new Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventricular tachycardia?
- Yes. Clin2 currently lists 75 recruiting ventricular tachycardia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventricular tachycardia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventricular tachycardia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.